Amid the prevailing trend of technological supremacy, the scientific research level plays a pivotal role in elevating economic growth and national comprehensive strength. As crucial forces propelling industrial advancement and economic expansion, high-tech companies share an intricate relationship between scientific research level and enterprise strengths. This study delves into the influence of research level on the financing capacity of enterprises in the STAR market. It employs Ordinary Least Squares (OLS) regression and Gradient Boosting Regression Trees (GBRT) techniques to analyze data between 2019 and 2022. The findings underscore that patent research capabilities and research investment intensity are key factors impacting financing capacity. Specifically, patent quantity exhibits a negative correlation with Asset-liability ratio (ALR), while research investment intensity shows a positive correlation. On the other hand, patent quantity correlates positively with commercial credit financing (CCF) capacity, whereas the proportion of research personnel correlates negatively. The GBRT analysis further validates the significant impact which patent quantity and research investment have on financing capacity. This suggests that high-tech companies should focus on enhancing research efficiency and the proportion of research personnel, while also carefully considering the degree of emphasis on innovation. These measures can balance CCF and debt ratio considerations. The study provides essential decision-making insights for managers and investors of technology-driven firms, emphasizing the significance of technological innovation in business development. Also, it offers guidance for optimizing corporate development and personnel structures in the technology and innovation sectors.
Read full abstract